Choroidal infarction following ophthalmic artery chemotherapy

BACKGROUND: Methylenetetrahydrofolate reductase (MTHFR) genetic mutations and intra-procedural inhaled nitrous oxide (N(2)O) independently increase blood levels of homocysteine, a compound associated with thrombosis. Patients with MTHFR mutations who also receive N(2)O during ophthalmic artery chemo...

Descripción completa

Detalles Bibliográficos
Autores principales: Bohm, Kelley J., Gobin, Y. Pierre, Francis, Jasmine H., McInerney, Gabrielle, Dabo-Trubelja, Anahita, Dalecki, Paul H., Marr, Brian P., Abramson, David H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5925835/
https://www.ncbi.nlm.nih.gov/pubmed/29736261
http://dx.doi.org/10.1186/s40942-018-0119-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5925835/
https://www.ncbi.nlm.nih.gov/pubmed/29736261
http://dx.doi.org/10.1186/s40942-018-0119-x

Ejemplares similares